Geneos Wealth Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.54M Sell
31,174
-4,750
-13% -$1.19M 0.15% 159
2025
Q4
$10.2M Buy
35,924
+1,664
+5% +$520K 0.25% 96
2025
Q3
$10.6M Buy
34,260
+1,995
+6% +$625K 0.27% 88
2025
Q2
$10.1M Sell
32,265
-42,300
-57% -$12.2M 0.25% 97
2025
Q1
$19.6M Buy
74,565
+44,439
+148% +$12M 0.28% 84
2024
Q4
$7.86M Buy
30,126
+12,244
+68% +$3.08M 0.28% 79
2024
Q3
$4.16M Buy
17,882
+8,213
+85% +$1.69M 0.16% 152
2024
Q2
$1.95M Buy
+9,669
New +$1.74M 0.09% 252
2022
Q1
Sell
-94
Closed -$25K 2927
2021
Q4
$25K Hold
94
﹤0.01% 1774
2021
Q3
$26K Hold
94
﹤0.01% 1790
2021
Q2
$26K Hold
94
﹤0.01% 1784
2021
Q1
$27K Hold
94
﹤0.01% 1923
2020
Q4
$24K Hold
94
﹤0.01% 1800
2020
Q3
$21K Buy
+94
New +$19.8K ﹤0.01% 1635

Other funds holding PODD

Geneos Wealth Management's PODD Position: Q1 2026 in Review

Geneos Wealth Management reduced its Insulet (PODD) stake by 13% in Q1 2026, selling an estimated $1.19M and leaving 31,174 shares worth $6.54M. The position accounts for 0.15% of the portfolio, ranked #159.

Geneos Wealth Management first reported a position in PODD in Q3 2020 and has held it in 14 quarters since. The position peaked at $19.6M in Q1 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Geneos Wealth Management held 31,174 shares of Insulet worth $6.54M as of Q1 2026.
  • Geneos Wealth Management sold 4,750 Insulet shares in Q1 2026, an estimated $1.19M.
  • Insulet made up 0.15% of Geneos Wealth Management's portfolio in Q1 2026, its #159 holding.
  • Geneos Wealth Management first reported a position in Insulet in Q3 2020 and has held it in 14 quarters since.
  • Geneos Wealth Management's Insulet position peaked at $19.6M in Q1 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.